{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:12:40Z","timestamp":1778055160917,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T00:00:00Z","timestamp":1382486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10157-013-0886-5","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T02:39:39Z","timestamp":1382409579000},"page":"225-229","source":"Crossref","is-referenced-by-count":5,"title":["A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy"],"prefix":"10.1007","volume":"18","author":[{"given":"Efstratios","family":"Stratikos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Chroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,23]]},"reference":[{"issue":"4","key":"886_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MOL.0b013e328345ebb0","volume":"22","author":"V Tsimihodimos","year":"2011","unstructured":"Tsimihodimos V, Elisaf M. Lipoprotein glomerulopathy. Curr Opin Lipidol. 2011;22(4):262\u20139.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"886_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","volume":"47","author":"T Saito","year":"2006","unstructured":"Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis. 2006;47(2):199\u2013211.","journal-title":"Am J Kidney Dis"},{"issue":"24","key":"886_CR3","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc072088","volume":"357","author":"BH Rovin","year":"2007","unstructured":"Rovin BH, Roncone D, McKinley A, Nadasdy T, Korbet SM, Schwartz MM. APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy. N Engl J Med. 2007;357(24):2522\u20134.","journal-title":"N Engl J Med"},{"issue":"3","key":"886_CR4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/j.ajkd.2005.12.031","volume":"47","author":"R Sam","year":"2006","unstructured":"Sam R, Wu H, Yue L, Mazzone T, Schwartz MM, Arruda JAL, et al. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding. Am J Kidney Dis. 2006;47(3):539\u201348.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"886_CR5","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/ndt\/gfq389","volume":"25","author":"AS Bomback","year":"2010","unstructured":"Bomback AS, Song H, D\u2019Agati VD, Cohen SD, Neal A, Appel GB, et al. A new apolipoprotein E mutation, apoE Las Vegas, in a European\u2013American with lipoprotein glomerulopathy. Nephrol Dial Transplant. 2010;25(10):3442\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"886_CR6","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1186\/1752-1947-3-9311","volume":"3","author":"G Russi","year":"2009","unstructured":"Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P, et al. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced extracorporeal lipoprotein precipitation system): a case report. J Med Case Rep. 2009;3:9311.","journal-title":"J Med Case Rep"},{"issue":"5","key":"886_CR7","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/S0041-1345(97)00409-0","volume":"29","author":"G Mourad","year":"1997","unstructured":"Mourad G, Cristol JP, TurcBaron C, Djamali A. Lipoprotein glomerulopathy: a new apolipoprotein-E-related disease that recurs after renal transplantation. Transplant Proc. 1997;29(5):2376.","journal-title":"Transplant Proc"},{"issue":"2","key":"886_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1050-1738(01)00148-7","volume":"12","author":"T Saito","year":"2002","unstructured":"Saito T, Ishigaki Y, Oikawa S, Yamamoto TT. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy. Trends Cardiovasc Med. 2002;12(2):67\u201370.","journal-title":"Trends Cardiovasc Med"},{"issue":"40","key":"886_CR9","doi-asserted-by":"crossref","first-page":"31269","DOI":"10.1074\/jbc.M005906200","volume":"275","author":"Y Ishigaki","year":"2000","unstructured":"Ishigaki Y, Oikawa S, Suzuki T, Usui S, Magoori K, Kim DH, et al. Virus-mediated transduction of apolipoprotein E (ApoE)-Sendai develops lipoprotein glomerulopathy in ApoE-deficient mice. J Biol Chem. 2000;275(40):31269\u201373.","journal-title":"J Biol Chem"},{"issue":"4852","key":"886_CR10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240(4852):622\u201330.","journal-title":"Science"},{"issue":"6","key":"886_CR11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-2275(20)38094-9","volume":"23","author":"VI Zannis","year":"1982","unstructured":"Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res. 1982;23(6):911\u20134.","journal-title":"J Lipid Res"},{"key":"886_CR12","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","volume":"50 Suppl","author":"RW Mahley","year":"2009","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J Lipid Res. 2009;50 Suppl:S183\u20138.","journal-title":"J Lipid Res"},{"issue":"13","key":"886_CR13","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1016\/S0021-9258(18)68779-4","volume":"263","author":"LP Aggerbeck","year":"1988","unstructured":"Aggerbeck LP, Wetterau JR, Weisgraber KH, Wu CS, Lindgren FT. Human apolipoprotein E3 in aqueous solution II. Properties of the amino- and carboxyl-terminal domains. J Biol Chem. 1988;263(13):6249\u201358.","journal-title":"J Biol Chem"},{"issue":"13","key":"886_CR14","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/S0021-9258(18)68778-2","volume":"263","author":"JR Wetterau","year":"1988","unstructured":"Wetterau JR, Aggerbeck LP, Rall SC Jr, Weisgraber KH. Human apolipoprotein E3 in aqueous solution I. Evidence for two structural domains. J Biol Chem. 1988;263(13):6240\u20138.","journal-title":"J Biol Chem"},{"issue":"36","key":"886_CR15","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.1106420108","volume":"108","author":"J Chen","year":"2011","unstructured":"Chen J, Li Q, Wang J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci USA. 2011;108(36):14813\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"35","key":"886_CR16","doi-asserted-by":"crossref","first-page":"9071","DOI":"10.1021\/bi800469r","volume":"47","author":"A Chroni","year":"2008","unstructured":"Chroni A, Pyrpassopoulos S, Thanassoulas A, Nounesis G, Zannis VI, Stratikos E. Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties. Biochemistry. 2008;47(35):9071\u201380.","journal-title":"Biochemistry"},{"key":"886_CR17","volume-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. The metabolic and molecular bases of inherited disease","author":"RW Mahley","year":"2001","unstructured":"Mahley RW, Rall SC Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001."},{"issue":"11","key":"886_CR18","doi-asserted-by":"crossref","first-page":"e27037","DOI":"10.1371\/journal.pone.0027037","volume":"6","author":"D Georgiadou","year":"2011","unstructured":"Georgiadou D, Chroni A, Vezeridis A, Zannis VI, Stratikos E. Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia. PLoS One. 2011;6(11):e27037.","journal-title":"PLoS One"},{"issue":"51","key":"886_CR19","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1021\/bi1017655","volume":"49","author":"D Nguyen","year":"2010","unstructured":"Nguyen D, Dhanasekaran P, Nickel M, Nakatani R, Saito H, Phillips MC, et al. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry. 2010;49(51):10881\u20139.","journal-title":"Biochemistry"},{"issue":"9","key":"886_CR20","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/db11-0466","volume":"60","author":"LA Johnson","year":"2011","unstructured":"Johnson LA, Arbones-Mainar JM, Fox RG, Pendse AA, Altenburg MK, Kim HS, et al. Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. Diabetes. 2011;60(9):2285\u201394.","journal-title":"Diabetes"},{"issue":"5123","key":"886_CR21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science"},{"issue":"32","key":"886_CR22","doi-asserted-by":"crossref","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","volume":"271","author":"LM Dong","year":"1996","unstructured":"Dong LM, Weisgraber KH. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem. 1996;271(32):19053\u20137.","journal-title":"J Biol Chem"},{"issue":"8","key":"886_CR23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nsb0896-718","volume":"3","author":"LM Dong","year":"1996","unstructured":"Dong LM, Parkin S, Trakhanov SD, Rupp B, Simmons T, Arnold KS, et al. Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat Struct Biol. 1996;3(8):718\u201322.","journal-title":"Nat Struct Biol"},{"issue":"3","key":"886_CR24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1681\/ASN.V123524","volume":"12","author":"M Hoffmann","year":"2001","unstructured":"Hoffmann M, Scharnagl H, Panagiotou E, Banghard W, Wieland H, Marz W. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy. J Am Soc Nephrol. 2001;12(3):524\u201330.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"886_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","volume":"56","author":"A Matsunaga","year":"1999","unstructured":"Matsunaga A, Sasaki J, Komatsu T, Kanatsu K, Tsuji E, Moriyama K, et al. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int. 1999;56(2):421\u20137.","journal-title":"Kidney Int"},{"issue":"2","key":"886_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/meta.2002.29990","volume":"51","author":"T Murano","year":"2002","unstructured":"Murano T, Matsumura R, Misawa Y, Ozaki H, Miyashita Y, Yoshida S, et al. Interaction of endothelial cells and triglyceride-rich lipoproteins with apolipoprotein E (Arg\u00a0\u2192\u00a0Cys) from a patient with lipoprotein glomerulopathy. Metabolism. 2002;51(2):201\u20135.","journal-title":"Metabolism"},{"key":"886_CR27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10157-001-8014-3","volume":"5","author":"T Saito","year":"2001","unstructured":"Saito T, Ishigaki Y, Oikawa S, Yamamoto TT. Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses. Clin Exp Nephrol. 2001;5:201\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"886_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1194\/jlr.M030965","volume":"54","author":"D Georgiadou","year":"2013","unstructured":"Georgiadou D, Stamatakis K, Efthimiadou EK, Kordas G, Gantz D, Chroni A, et al. Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy. J Lipid Res. 2013;54(1):164\u201376.","journal-title":"J Lipid Res"},{"issue":"21","key":"886_CR29","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/jm3008618","volume":"55","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y. Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology. J Med Chem. 2012;55(21):8997\u20139008.","journal-title":"J Med Chem"},{"issue":"15","key":"886_CR30","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2006;103(15):5644\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"886_CR31","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","volume":"287","author":"HK Chen","year":"2012","unstructured":"Chen HK, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, et al. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem. 2012;287(8):5253\u201366.","journal-title":"J Biol Chem"},{"issue":"19","key":"886_CR32","doi-asserted-by":"crossref","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","volume":"286","author":"J Brodbeck","year":"2011","unstructured":"Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, Jeong DE, et al. Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem. 2011;286(19):17217\u201326.","journal-title":"J Biol Chem"},{"issue":"1","key":"886_CR33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ndt\/gfm735","volume":"23","author":"M Hagiwara","year":"2008","unstructured":"Hagiwara M, Yamagata K, Matsunaga T, Arakawa Y, Usui J, Shimizu Y, et al. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy. Nephrol Dial Transplant. 2008;23(1):381\u20134.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"886_CR34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000045513","volume":"83","author":"K Konishi","year":"1999","unstructured":"Konishi K, Saruta T, Kuramochi S, Oikawa S, Saito T, Han H, et al. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy. Nephron. 1999;83(3):214\u20138.","journal-title":"Nephron"},{"issue":"2","key":"886_CR35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004670050032","volume":"14","author":"T Ogawa","year":"2000","unstructured":"Ogawa T, Maruyama K, Hattori H, Arai H, Kondoh I, Egashira T, et al. A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy. Pediatr Nephrol. 2000;14(2):149\u201351.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"886_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s004670050264","volume":"11","author":"K Maruyama","year":"1997","unstructured":"Maruyama K, Arai H, Ogawa T, Tomizawa S, Morikawa A. Lipoprotein glomerulopathy: a pediatric case report. Pediatr Nephrol. 1997;11(2):213\u20134.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"886_CR37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1681\/ASN.V85820","volume":"8","author":"S Oikawa","year":"1997","unstructured":"Oikawa S, Matsunaga A, Saito T, Sato H, Seki T, Hoshi K, et al. Apolipoprotein E Sendai (arginine 145\u00a0\u2192\u00a0proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol. 1997;8(5):820\u20133.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"886_CR38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000111828","volume":"28","author":"B Luo","year":"2008","unstructured":"Luo B, Huang F, Liu Q, Li X, Chen W, Zhou SF, et al. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. Am J Nephrol. 2008;28(2):347\u201353.","journal-title":"Am J Nephrol"},{"issue":"2","key":"886_CR39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ndt\/gfm675","volume":"23","author":"M Kinomura","year":"2008","unstructured":"Kinomura M, Sugiyama H, Saito T, Matsunaga A, Sada KE, Kanzaki M, et al. A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy. Nephrol Dial Transplant. 2008;23(2):751\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"886_CR40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5551\/jat.7377","volume":"18","author":"A Mitani","year":"2011","unstructured":"Mitani A, Ishigami M, Watase K, Minakata T, Yamamura T. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy. J Atheroscler Thromb. 2011;18(6):531\u20135.","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"886_CR41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5551\/jat.8102","volume":"18","author":"T Tokura","year":"2011","unstructured":"Tokura T, Itano S, Kobayashi S, Kuwabara A, Fujimoto S, Horike H, et al. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy. J Atheroscler Thromb. 2011;18(6):536\u201341.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"886_CR42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1523-1755.1999.00677.x","volume":"56","author":"M Ando","year":"1999","unstructured":"Ando M, Sasaki J, Hua H, Matsunaga A, Uchida K, Jou K, et al. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy. Kidney Int. 1999;56(4):1317\u201323.","journal-title":"Kidney Int"},{"issue":"1","key":"886_CR43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/102490790801500111","volume":"15","author":"CY Cheung","year":"2009","unstructured":"Cheung CY, Chan AO, Chan YH, Lee KC, Chan GP, Lau GT, et al. A rare cause of nephrotic syndrome: lipoprotein glomerulopathy. Hong Kong Med J. 2009;15(1):57\u201360.","journal-title":"Hong Kong Med J"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0886-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0886-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T21:16:35Z","timestamp":1646860595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0886-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,23]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0886-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,23]]}}}